Name:	O
___	O
Unit	O
No:	O
___	O
Admission	O
Date:	O
___	O
Discharge	O
Date:	O
___	O
Date	O
of	O
Birth:	O
___	O
Sex:	O
M	O
Service:	O
MEDICINE	O
Allergies:	O
No	O
Known	O
Allergies	O
/	O
Adverse	O
Drug	O
Reactions	O
Attending:	O
___	O
Chief	O
Complaint:	O
Lethargy	O
Major	O
Surgical	O
or	O
Invasive	O
Procedure:	O
None	O
History	O
of	O
Present	O
Illness:	O
Mr.	O
___	O
is	O
a	O
___	O
yo	O
M	O
w/hx	O
of	O
PVD,	O
DM,	O
Alzheimer's	B-Dementia
dementia,	B-Dementia
CAD,	O
CVA,	O
HTN,	O
paranoia	B-Dementia
who	O
presents	O
from	O
___	O
with	O
lethargy.	O
Per	O
reports	O
he	O
had	O
decreased	O
PO	O
intake	O
and	O
some	O
low	O
back	O
pain.	O
Labs	O
were	O
checked	O
and	O
he	O
was	O
found	O
to	O
have	O
a	O
creatinine	O
of	O
2.4	O
at	O
his	O
assisted	O
living.	O
He	O
was	O
brought	O
to	O
___.	O
.	O
In	O
the	O
ED,	O
initial	O
vs	O
were:	O
T99.1	O
P70	O
BP130/60	O
R18	O
O2	O
sat	O
97%	O
RA.	O
He	O
was	O
without	O
complaints.	O
Glucose	O
was	O
checked	O
and	O
was	O
51.	O
He	O
was	O
given	O
1amp	O
D50	O
and	O
reportedly	O
his	O
lethargy	O
improved.	O
Labs	O
were	O
sent	O
an	O
troponin	O
was	O
0.32.	O
ECG	O
was	O
not	O
concerning	O
for	O
ischemia.	O
Cardiology	O
was	O
called	O
and	O
recommended	O
no	O
heparin	O
at	O
this	O
time.	O
He	O
was	O
given	O
600mg	O
Aspirin	O
PR	O
and	O
2.5mg	O
IV	O
Lopressor.	O
Repeat	O
glucose	O
was	O
123.	O
Creatinine	O
was	O
noted	O
to	O
be	O
2.7.	O
Guaiac	O
was	O
positive.	O
HCT	O
was	O
24.4.	O
.	O
On	O
the	O
floor,	O
he	O
has	O
no	O
complaints.	O
He	O
denies	O
chest	O
pain	O
and	O
does	O
not	O
recall	O
having	O
chest	O
pain	O
in	O
the	O
last	O
several	O
weeks.	O
He	O
reports	O
his	O
last	O
bowel	O
movement	O
was	O
3	O
days	O
ago.	O
.	O
Review	O
of	O
systems:	O
(+)	O
constipation	B-Constipation
(-)	O
Denies	O
fever,	O
chills,	O
night	O
sweats,	O
recent	O
weight	B-Weight_loss
loss	B-Weight_loss
or	O
gain.	O
Denies	O
headache,	O
sinus	O
tenderness,	O
rhinorrhea	O
or	O
congestion.	O
Denied	O
cough,	O
shortness	O
of	O
breath.	O
Denied	O
chest	O
pain	O
or	O
tightness,	O
palpitations.	O
Denied	O
nausea,	O
vomiting,	O
diarrhea,	O
or	O
abdominal	O
pain.	O
No	O
recent	O
change	O
in	O
bladder	O
habits.	O
No	O
dysuria.	O
Denied	O
arthralgias	O
or	O
myalgias.	O
Past	O
Medical	O
History:	O
PVD	O
s/p	O
multiple	O
toe	O
amputations	O
Encephalopathy	B-Delirium
(EtOH)	O
Alzheimer's	B-Dementia
dementia	B-Dementia
(Alzheimers)	O
with	O
occasional	O
paranoia	B-Dementia
and	O
visual	B-Visual_impairment
hallucinations	B-Visual_impairment
DM2	O
with	O
history	O
of	O
DKA	O
CAD	O
s/p	O
NSTEMI	O
HTN	O
Social	O
History:	O
___	O
Family	O
History:	O
Non-contributory	O
Physical	O
Exam:	O
Vitals:	O
T:	O
96.1	O
BP:	O
100/70	O
P:	O
63	O
R:	O
18	O
O2:	O
100%	O
RA	O
General:	O
Well	O
appearing	O
___	O
man,	O
Alert,	O
oriented	B-Unspecified_cognitive_impairment
x	B-Unspecified_cognitive_impairment
1	B-Unspecified_cognitive_impairment
HEENT:	O
Sclera	O
anicteric,	O
MMM,	O
oropharynx	O
clear	O
Neck:	O
supple,	O
JVP	O
not	O
elevated,	O
no	O
LAD	O
Lungs:	O
Clear	O
to	O
auscultation	O
bilaterally,	O
no	O
wheezes,	O
rales,	O
ronchi	O
CV:	O
Regular	O
rate	O
and	O
rhythm,	O
normal	O
S1	O
+	O
S2,	O
no	O
murmurs,	O
rubs,	O
gallops	O
Abdomen:	O
soft,	O
non-tender,	O
mildly	O
distended,	O
bowel	O
sounds	O
present,	O
no	O
rebound	O
tenderness	O
or	O
guarding,	O
no	O
organomegaly	O
Ext:	O
R	O
metatarsal	O
amputation	O
which	O
is	O
clean	O
and	O
dry,	O
L	O
___	O
toe	O
ampuatated	O
and	O
appears	O
clean.	O
2cm	O
pressure	B-Pressure_injury
ulcer	B-Pressure_injury
on	O
R	O
heel	B-Pressure_injury
which	O
is	O
clean.	O
.	O
Pertinent	O
Results:	O
___	O
CXR:	O
Small	O
opacity	O
in	O
the	O
left	O
posterior	O
basal	O
segment	O
of	O
the	O
left	O
lower	O
lobe,	O
could	O
represent	O
an	O
acute	O
infection.	O
.	O
___	O
ECHO:	O
The	O
left	O
atrium	O
is	O
elongated.	O
No	O
atrial	O
septal	O
defect	O
is	O
seen	O
by	O
2D	O
or	O
color	O
Doppler.	O
There	O
is	O
mild	O
symmetric	O
left	O
ventricular	O
hypertrophy	O
with	O
normal	O
cavity	O
size	O
and	O
regional/global	O
systolic	O
function	O
(LVEF>55%).	O
There	O
is	O
no	O
ventricular	O
septal	O
defect.	O
Right	O
ventricular	O
chamber	O
size	O
and	O
free	O
wall	O
motion	O
are	O
normal.	O
The	O
diameters	O
of	O
aorta	O
at	O
the	O
sinus,	O
ascending	O
and	O
arch	O
levels	O
are	O
normal.	O
The	O
aortic	O
valve	O
leaflets	O
(3)	O
are	O
mildly	O
thickened	O
but	O
aortic	O
stenosis	O
is	O
not	O
present.	O
No	O
aortic	O
regurgitation	O
is	O
seen.	O
The	O
mitral	O
valve	O
leaflets	O
are	O
mildly	O
thickened.	O
There	O
is	O
no	O
mitral	O
valve	O
prolapse.	O
Mild	O
(1+)	O
mitral	O
regurgitation	O
is	O
seen.	O
The	O
tricuspid	O
valve	O
leaflets	O
are	O
mildly	O
thickened.	O
The	O
estimated	O
pulmonary	O
artery	O
systolic	O
pressure	O
is	O
normal.	O
There	O
is	O
no	O
pericardial	O
effusion.	O
.	O
___	O
CT	B-Intracranial_haemorrhage
head:	B-Intracranial_haemorrhage
1.	O
No	O
acute	O
intracranial	B-Intracranial_haemorrhage
process;	O
if	O
concern	O
for	O
acute	O
infarct,	O
MR	O
is	O
more	O
sensitive.	O
2.	O
Old	O
left	O
frontal	O
and	O
left	O
basal	O
ganglia	O
hypodensities	O
likely	O
due	O
to	O
old	O
infarcts.	O
.	O
___	O
MRI	O
brain:	O
MRI	B-Intracranial_haemorrhage
BRAIN,	B-Intracranial_haemorrhage
WITHOUT	O
IV	O
CONTRAST:	O
There	O
is	O
no	O
evidence	O
of	O
acute	O
hemorrhage	B-Intracranial_haemorrhage
or	O
acute	O
infarction.	O
Prominence	O
of	O
the	O
sulci	O
and	O
ventricles	O
is	O
consistent	O
with	O
moderate	O
atrophy.	O
Old	O
lacunar	O
infarcts	O
are	O
seen	O
in	O
the	O
left	O
putamen	O
and	O
corona	O
radiata,	O
unchanged.	O
Foci	O
of	O
periventricular	O
and	O
subcortical	O
white	O
matter	O
hyperintense	O
signal	O
are	O
consistent	O
with	O
small	O
vessel	O
ischemic	O
disease.	O
Area	O
of	O
susceptibility	O
artifact	O
in	O
the	O
left	O
cingulate	O
gyrus	O
is	O
consistent	O
with	O
old	O
blood	O
products	O
(4:17).	O
There	O
is	O
no	O
shift	O
of	O
normally	O
midline	O
structures.	O
No	O
abnormal	O
signal	O
is	O
seen	O
in	O
the	O
visualized	O
paranasal	O
sinuses	O
and	O
mastoid	O
air	O
cells.	O
Incidental	O
note	O
is	O
made	O
of	O
a	O
disc	O
protrusion	O
at	O
C3-4	O
level	O
(3:15).	O
IMPRESSIONS:	O
1.	O
No	O
evidence	O
of	O
acute	O
infarction.	O
2.	O
Evidence	O
of	O
global	O
atrophy,	O
old	O
lacunar	O
infarct,	O
old	O
blood	O
products,	O
and	O
small	O
vessel	O
ischemic	O
disease,	O
as	O
described	O
above.	O
.	O
Brief	O
Hospital	O
Course:	O
LETHARGY:	O
Patient's	O
lethargy	O
on	O
presentation	O
to	O
the	O
hospital	O
was	O
likely	O
multifactorial.	O
He	O
was	O
hypoglycemic	O
with	O
glucose	O
<	O
60.	O
He	O
appeared	O
dehydrated	O
on	O
exam	O
with	O
elevated	O
creatinine	O
to	O
2.7	O
(baseline	O
1.7).	O
He	O
had	O
an	O
elevated	O
troponin	O
suggesting	O
recent	O
NSTEMI.	O
He	O
complained	O
of	O
significant	O
constipation.	B-Constipation
His	O
acamprosate	O
was	O
decreased	O
to	O
333	O
mg	O
po	O
tid	O
and	O
then	O
ultimately	O
discontinued.	O
His	O
clonidine	O
was	O
decreased.	O
He	O
was	O
given	O
an	O
amp	O
of	O
D50,	O
2	O
L	O
IV	O
fluids,	O
and	O
an	O
aggressive	O
bowel	O
regimen.	O
With	O
resolution	O
of	O
his	O
hypoglycemia,	O
uremia,	O
constipation	B-Constipation
and	O
dehydration	O
his	O
mental	O
status	O
improved.	O
.	O
UNRESPONSIVENESS:	O
Patient	O
had	O
decreased	O
attentiveness	O
on	O
the	O
morning	O
of	O
___.	O
He	O
was	O
also	O
found	O
to	O
have	O
a	O
right	O
sided	O
facial	O
droop.	O
The	O
chronicity	O
of	O
the	O
facial	O
droop	O
was	O
uncertain.	O
Family	O
friend,	O
___,	O
was	O
visiting	O
that	O
morning	O
and	O
stated	O
that	O
the	O
facial	O
droop	O
was	O
new.	O
CT	O
head	O
was	O
performed	O
emergently	O
showing	O
no	O
evidence	O
of	O
bleeding.	O
Later	O
that	O
afternoon	O
patient	O
was	O
found	O
to	O
be	O
sleeping	O
but	O
did	O
not	O
wake	O
to	O
verbal	O
or	O
painful	O
stimuli.	O
He	O
received	O
no	O
sedating	O
medications.	O
Vital	O
signs	O
were	O
within	O
normal	O
limits,	O
EKG	O
was	O
unchanged,	O
ABG	O
was	O
normal,	O
glucose	O
was	O
209.	O
Patient	O
remained	O
hemodynamically	O
stable	O
though	O
he	O
did	O
not	O
respond	O
to	O
painful	O
stimuli.	O
He	O
started	O
to	O
wake	O
up	O
a	O
few	O
hours	O
later	O
and	O
the	O
following	O
day	O
was	O
reportedly	O
(per	O
family	O
friend)	O
at	O
his	O
baseline	O
mental	O
status.	O
Given	O
the	O
abrupt	O
change	B-Delirium
in	B-Delirium
mental	B-Delirium
status	B-Delirium
and	O
concern	O
for	O
new	O
facial	O
droop	O
an	O
MRI	O
was	O
performed	O
prior	O
to	O
discharge.	O
The	O
final	O
report	O
of	O
the	O
MRI	O
was	O
pending	O
at	O
the	O
time	O
of	O
discharge	O
but	O
preliminary	O
report	O
was	O
negative	O
for	O
acute	O
stroke.	O
Etiology	O
for	O
patient's	O
unresponsive	O
episode	O
remains	O
unclear.	O
This	O
likely	O
represents	O
hypoactive	O
delirium	B-Delirium
in	O
the	O
setting	O
of	O
poor	O
sleep	O
for	O
multiple	O
days.	O
.	O
ACUTE	O
ON	O
CHRONIC	O
RENAL	O
FAILURE:	O
Patient's	O
creatinine	O
was	O
elevated	O
to	O
2.7	O
(up	O
from	O
baseline	O
of	O
1.7)	O
on	O
presentation.	O
With	O
holding	O
his	O
HCTZ	O
and	O
giving	O
IV	O
fluids	O
his	O
renal	O
function	O
improved	O
to	O
his	O
baseline.	O
Recommend	O
monitoring	O
his	O
renal	O
function	O
within	O
a	O
few	O
days	O
of	O
discharge.	O
.	O
NSTEMI:	O
Patient	O
was	O
found	O
to	O
have	O
an	O
elevated	O
troponin	O
on	O
presentation	O
(peaked	O
on	O
admission	O
at	O
0.32).	O
The	O
absence	O
of	O
acute	O
EKG	O
changes,	O
the	O
absence	O
of	O
elevated	O
CKs,	O
and	O
the	O
down	O
trending	O
troponin	O
made	O
an	O
acute	O
MI	O
unlikely.	O
This	O
likely	O
represented	O
a	O
recent	O
NSTEMI.	O
He	O
was	O
continued	O
on	O
his	O
home	O
high	O
dose	O
statin,	O
plavix,	O
beta	O
blocker.	O
His	O
aspirin	O
was	O
increased	O
to	O
325	O
mg	O
daily.	O
Patient	O
was	O
monitored	O
on	O
telemetry	O
throughout	O
hospitalization	O
without	O
events.	O
He	O
had	O
an	O
echocardiogram	O
performed	O
on	O
day	O
of	O
discharge	O
showing	O
left	O
ventricular	O
hypertrophy,	O
no	O
significant	O
wall	O
motion	O
abnormalities,	O
and	O
EF	O
of	O
>	O
55%.	O
Recommend	O
continuing	O
medical	O
management	O
including	O
improving	O
glucose	O
and	O
blood	O
pressure	O
control.	O
.	O
DM2:	O
On	O
presentation	O
patient	O
was	O
hypoglycemic	O
and	O
home	O
insulin	O
regimen	O
was	O
held.	O
Patient's	O
acute	O
renal	O
failure	O
likely	O
contributed	O
to	O
decreased	O
insulin	O
clearance	O
and	O
subsequent	O
hypoglycemia.	O
On	O
day	O
three	O
of	O
admission	O
patient	O
was	O
restarted	O
on	O
low	O
dose	O
glargine	O
15	O
units	O
qam	O
and	O
sliding	O
scale	O
humalog.	O
Patient's	O
glucose	O
became	O
poorly	O
controlled	O
(glucose	O
>	O
350)	O
the	O
following	O
day	O
and	O
his	O
glargine	O
was	O
increased	O
to	O
25	O
units.	O
Recommend	O
patient	O
increase	O
insulin	O
to	O
30	O
units	O
of	O
glargine	O
daily	O
and	O
continue	O
diabetic	O
diet	O
and	O
sliding	O
scale	O
humalog	O
with	O
meals.	O
If	O
glucose	O
allows	O
and	O
renal	O
function	O
remains	O
stable	O
will	O
likely	O
be	O
able	O
to	O
restart	O
prior	O
dose	O
of	O
glargine	O
34	O
units	O
daily.	O
.	O
HTN:	O
Blood	O
pressure	O
well	O
controlled	O
on	O
presentation.	O
Due	O
to	O
renal	O
failure	O
hydrochlorothiazide	O
was	O
discontinued.	O
His	O
clonidine	O
dose	O
was	O
also	O
reduced	O
due	O
to	O
patient's	O
lethargy	O
to	O
0.1	O
mg	O
tid.	O
After	O
receiving	O
IV	O
fluids	O
and	O
becoming	O
more	O
responsive	O
his	O
blood	O
pressure	O
became	O
elevated.	O
His	O
clonidine	O
dose	O
was	O
returned	O
to	O
his	O
home	O
dose	O
of	O
0.3	O
mg	O
po	O
tid	O
prior	O
to	O
discharge.	O
Patient	O
was	O
continued	O
on	O
metroprolol	O
200	O
mg	O
po	O
bid	O
and	O
amlodipine	O
10	O
mg	O
daily.	O
Recommend	O
ensuring	O
patient	O
has	O
adequate	O
po	O
intake	O
and	O
stable	O
renal	O
function	O
prior	O
to	O
restarting	O
hydrochlorothiazide.	O
.	O
HEAL	B-Pressure_injury
ULCER:	B-Pressure_injury
Patient	O
was	O
found	O
to	O
have	O
a	O
pressure	B-Pressure_injury
ulcer	B-Pressure_injury
on	O
his	O
left	O
heal.	B-Pressure_injury
Wound	O
care	O
team	O
was	O
consulted	O
who	O
recommended:	O
-cleanse	O
skin/ulcer	O
with	O
wound	O
cleanser	O
and	O
pat	O
dry	O
-apply	O
aloe	O
vesta	O
moisturizer	O
to	O
intact	O
dry	O
skin	O
-cover	O
wound	O
with	O
a	O
piece	O
of	O
MOISTENED	O
aquacel/ag	O
sheet(discontinue	O
after	O
2	O
weeks	O
)	O
-followed	O
by	O
dry	O
gauze	O
-wrap	O
with	O
Kerlix	O
-change	O
dressing	O
daily	O
GOALS	O
OF	O
CARE:	O
Patient's	O
dementia	B-Dementia
and	O
altered	B-Delirium
mental	B-Delirium
status	B-Delirium
prevented	O
him	O
from	O
contributing	O
to	O
goals	O
of	O
care	O
discussions	O
during	O
this	O
hospitalization.	O
Patient's	O
health	O
care	O
proxy	O
is	O
apparently	O
his	O
only	O
living	O
relative	O
his	O
neice	O
___.	O
Unfortunately,	O
she	O
was	O
on	O
a	O
cruise	O
for	O
the	O
holidays	O
and	O
she	O
was	O
not	O
able	O
to	O
be	O
reached	O
during	O
this	O
hospitalization.	O
Patient's	O
friend,	O
___,	O
was	O
at	O
his	O
bedside	O
daily	O
during	O
his	O
admission.	O
She	O
stated	O
that	O
she	O
had	O
talked	O
to	O
the	O
patient	O
and	O
the	O
health	O
care	O
proxy	O
and	O
she	O
felt	O
strongly	O
that	O
Mr.	O
___	O
would	O
not	O
want	O
aggressive	O
treatments	O
or	O
invasive	O
procedures	O
if	O
his	O
health	O
were	O
to	O
further	O
decline.	O
She	O
believed	O
that	O
he	O
would	O
favor	O
comfort	O
measures	O
over	O
resuscitation.	O
Because	O
she	O
is	O
not	O
the	O
health	O
care	O
proxy	O
and	O
the	O
patient	O
does	O
not	O
have	O
capacity	O
to	O
make	O
these	O
decisions	O
the	O
patient	O
remained	O
FULL	O
CODE	O
during	O
his	O
admission.	O
We	O
strongly	O
recommend	O
that	O
his	O
goals	O
of	O
care	O
and	O
code	O
status	O
be	O
addressed	O
with	O
his	O
health	O
care	O
proxy	O
when	O
she	O
is	O
able	O
to	O
be	O
reached.	O
Medications	O
on	O
Admission:	O
Aspirin	O
81mg	O
PO	O
daily	O
Enulose	O
10gm	O
PO	O
daily	O
Iron	O
325mg	O
PO	O
daily	O
Folic	O
Acid	O
1mg	O
PO	O
daily	O
Plavix	O
75mg	O
PO	O
daily	O
Vitamin	O
B1	O
100mg	O
PO	O
daily	O
Zyprexa	O
5mg	O
PO	O
qHS	O
Prilosec	O
20mg	O
PO	O
daily	O
Simvastatin	O
80mg	O
PO	O
daily	O
Colace	O
100mg	O
PO	O
daily	O
Calcium	O
with	O
Vit	O
D	O
500/200	O
PO	O
BID	O
Timolol	O
0.5%	O
opth	O
solution	O
1	O
drop	O
each	O
eye	O
BID	O
Campral	O
666mg	O
PO	O
TID	O
Pilocarpine	O
4%	O
1	O
drop	O
each	O
eye	O
q6H	O
Amlodipine	O
10mg	O
PO	O
qHS	O
Senna	O
8.6mg	O
2	O
tabs	O
HS	O
Travatan/Benzal	O
0.004%	O
1	O
drop	O
each	O
eye	O
qHS	O
Clonidione	O
0.3mg	O
PO	O
TID	O
Metoprolol	O
200mg	O
PO	O
BID	O
Lantus	O
34unts	O
SC	O
daily	O
Humalog	O
SS	O
HCTZ	O
12.5mg	O
PO	O
daily	O
Depakote	O
125mg	O
sprinkles	O
PO	O
daily	O
at	O
5pm	O
Discharge	O
Medications:	O
1.	O
aspirin	O
325	O
mg	O
Tablet	O
Sig:	O
One	O
(1)	O
Tablet	O
PO	O
DAILY	O
(Daily).	O
2.	O
senna	O
8.6	O
mg	O
Tablet	O
Sig:	O
Two	O
(2)	O
Tablet	O
PO	O
at	O
bedtime.	O
3.	O
docusate	O
sodium	O
100	O
mg	O
Capsule	O
Sig:	O
One	O
(1)	O
Capsule	O
PO	O
BID	O
(2	O
times	O
a	O
day).	O
4.	O
ferrous	O
sulfate	O
300	O
mg	O
(60	O
mg	O
Iron)	O
Tablet	O
Sig:	O
One	O
(1)	O
Tablet	O
PO	O
DAILY	O
(Daily).	O
5.	O
folic	O
acid	O
1	O
mg	O
Tablet	O
Sig:	O
One	O
(1)	O
Tablet	O
PO	O
DAILY	O
(Daily).	O
6.	O
clopidogrel	O
75	O
mg	O
Tablet	O
Sig:	O
One	O
(1)	O
Tablet	O
PO	O
DAILY	O
(Daily).	O
7.	O
amlodipine	O
5	O
mg	O
Tablet	O
Sig:	O
Two	O
(2)	O
Tablet	O
PO	O
DAILY	O
(Daily).	O
8.	O
clonidine	O
0.1	O
mg	O
Tablet	O
Sig:	O
Three	O
(3)	O
Tablet	O
PO	O
TID	O
(3	O
times	O
a	O
day).	O
9.	O
B	O
complex	O
vitamins	O
Capsule	O
Sig:	O
One	O
(1)	O
Cap	O
PO	O
DAILY	O
(Daily).	O
10.	O
metoprolol	O
tartrate	O
50	O
mg	O
Tablet	O
Sig:	O
Four	O
(4)	O
Tablet	O
PO	O
BID	O
(2	O
times	O
a	O
day).	O
11.	O
simvastatin	O
40	O
mg	O
Tablet	O
Sig:	O
Two	O
(2)	O
Tablet	O
PO	O
DAILY	O
(Daily).	O
12.	O
calcium	O
carbonate	O
200	O
mg	O
(500	O
mg)	O
Tablet,	O
Chewable	O
Sig:	O
Two	O
(2)	O
Tablet,	O
Chewable	O
PO	O
BID	O
(2	O
times	O
a	O
day).	O
13.	O
cholecalciferol	O
(vitamin	O
D3)	O
400	O
unit	O
Tablet	O
Sig:	O
Two	O
(2)	O
Tablet	O
PO	O
DAILY	O
(Daily).	O
14.	O
pilocarpine	O
HCl	O
4	O
%	O
Drops	O
Sig:	O
One	O
(1)	O
Drop	O
Ophthalmic	O
Q6H	O
(every	O
6	O
hours).	O
15.	O
timolol	O
maleate	O
0.5	O
%	O
Drops	O
Sig:	O
One	O
(1)	O
Drop	O
Ophthalmic	O
BID	O
(2	O
times	O
a	O
day).	O
16.	O
latanoprost	O
0.005	O
%	O
Drops	O
Sig:	O
One	O
(1)	O
Drop	O
Ophthalmic	O
HS	O
(at	O
bedtime).	O
17.	O
omeprazole	O
20	O
mg	O
Capsule,	O
Delayed	O
Release(E.C.)	O
Sig:	O
One	O
(1)	O
Capsule,	O
Delayed	O
Release(E.C.)	O
PO	O
DAILY	O
(Daily).	O
18.	O
olanzapine	O
2.5	O
mg	O
Tablet	O
Sig:	O
Two	O
(2)	O
Tablet	O
PO	O
HS	O
(at	O
bedtime).	O
19.	O
divalproex	O
___	O
mg	O
Capsule,	O
Sprinkle	O
Sig:	O
One	O
(1)	O
Capsule,	O
Sprinkle	O
PO	O
QPM	O
(once	O
a	O
day	O
(in	O
the	O
evening)).	O
20.	O
Enulose	O
10	O
gram/15	O
mL	O
Solution	O
Sig:	O
___	O
PO	O
three	O
times	O
a	O
day	O
as	O
needed	O
for	O
constipation.	B-Constipation
21.	O
Insulin	O
Please	O
restart	O
glargine	O
at	O
30	O
units	O
qam	O
and	O
titrate	O
back	O
up	O
to	O
prior	O
dose	O
of	O
34	O
units	O
qam	O
if	O
glucose	O
allows	O
and	O
renal	O
function	O
remains	O
stable.	O
Please	O
continue	O
prior	O
Humalog	O
sliding	O
scale	O
with	O
meals	O
and	O
at	O
bedtime.	O
22.	O
Outpatient	O
Lab	O
Work	O
Please	O
monitor	O
sodium,	O
potassium,	O
chloride,	O
bicarb,	O
BUN,	O
creatinine,	O
magnesium,	O
calcium,	O
phosphate	O
prior	O
to	O
___.	O
Results	O
should	O
be	O
reviewed	O
by	O
___	O
care	O
provider.	O
Discharge	O
Disposition:	O
Extended	O
Care	O
Facility:	O
___	O
Discharge	O
Diagnosis:	O
NSTEMI	O
Acute	O
renal	O
failure	O
secondary	O
to	O
dehydration	O
Hypoglycemia	O
Hyperglycemia	O
Lethargy/hypoactive	O
delirium	B-Delirium
Constipation	B-Constipation
Left	O
heal	B-Pressure_injury
pressure	B-Pressure_injury
ulcer	B-Pressure_injury
Discharge	O
Condition:	O
Patient	O
is	O
alert,	O
oriented	B-Delirium
to	O
himself,	O
his	O
birthday,	O
and	O
'hospital',	O
he	O
admits	O
to	O
chronic	O
intermittent	O
visual	B-Dementia
hallucinations,	B-Dementia
denies	O
thoughts	O
of	O
suicide	O
or	O
homicide.	O
He	O
has	O
slight	O
right	O
sided	O
facial	O
droop.	O
He	O
is	O
able	O
to	O
move	O
his	O
extremities	O
with	O
nearly	O
symmetric	O
strength	O
in	O
his	O
upper	O
extremities	O
(right	O
slightly	O
weaker	O
than	O
left	O
upper	O
extremity).	O
He	O
tolerates	O
oral	O
diet	O
and	O
medications.	O
Discharge	O
Instructions:	O
You	O
were	O
brought	O
to	O
the	O
hospital	O
after	O
being	O
found	O
to	O
be	O
lethargic.	O
You	O
were	O
found	O
to	O
be	O
very	O
dehydrated	O
with	O
evidence	O
of	O
increased	O
kidney	O
damage,	O
severe	O
constipation,	B-Constipation
low	O
blood	O
sugars,	O
and	O
likely	O
a	O
recent	O
heart	O
attack.	O
A	O
few	O
of	O
your	O
sedating	O
medications	O
were	O
reduced.	O
You	O
were	O
given	O
IV	O
fluids	O
and	O
your	O
symptoms	O
improved.	O
Your	O
kidney	O
function	O
returned	O
to	O
your	O
baseline.	O
You	O
were	O
gradually	O
restarted	O
on	O
your	O
insulin	O
as	O
your	O
kidney	O
function	O
and	O
appetite	O
improved.	O
Your	O
heart	O
disease	O
was	O
managed	O
with	O
medications.	O
On	O
the	O
afternoon	O
of	O
___	O
you	O
were	O
found	O
to	O
be	O
unresponsive.	O
You	O
were	O
immediately	O
evaluated	O
and	O
all	O
of	O
your	O
blood	O
work,	O
glucose,	O
and	O
vital	O
signs	O
were	O
within	O
normal	O
limits.	O
You	O
awoke	O
up	O
a	O
few	O
hours	O
later	O
and	O
returned	O
to	O
your	O
baseline	O
mental	O
status.	O
You	O
underwent	O
CT	O
of	O
your	O
head	O
and	O
MRI	O
of	O
your	O
brain	O
which	O
did	O
not	O
reveal	O
the	O
cause	O
of	O
your	O
unresponsive	O
episode.	O
This	O
episode	O
was	O
likely	O
due	O
to	O
delirium	B-Delirium
and	O
several	O
days	O
of	O
poor	O
sleep	O
and	O
agitation	B-Dementia
during	O
this	O
admission.	O
The	O
following	O
changes	O
were	O
made	O
to	O
your	O
home	O
medications.	O
1)	O
Increase	O
aspirin	O
from	O
81	O
mg	O
to	O
325	O
mg	O
daily	O
given	O
the	O
suspicion	O
of	O
a	O
recent	O
heart	O
attack.	O
2)	O
STOP	O
Acamprosate	O
the	O
medication	O
for	O
your	O
alcohol	O
dependence	O
as	O
this	O
can	O
be	O
sedating.	O
3)	O
HOLD	O
hydrochlorothiazide	O
pending	O
stable	O
kidney	O
function.	O
4)	O
Increase	O
docusate	O
to	O
100	O
mg	O
by	O
mouth	O
bid	O
to	O
help	O
prevent	O
constipation.	B-Constipation
5)	O
Increase	O
Enulose	O
to	O
___	O
mg	O
by	O
mouth	O
up	O
to	O
three	O
times	O
a	O
day	O
to	O
prevent	O
and	O
treat	O
constipation.	B-Constipation
6)	O
Decrease	O
clonidine	O
to	O
0.1	O
mg	O
po	O
tid	O
as	O
this	O
may	O
have	O
been	O
contributing	O
to	O
your	O
lethargy.	O
Followup	O
Instructions:	O
___	O

